Entry |
|
Name |
AGE-RAGE signaling pathway
|
Definition |
AGE -> AGER -> RAS -> RAF -> MEK -> ERK -> NFKB => (TNF,IL6,NOS2) |
Expanded |
(C21011,C21012,C21013,C21014) -> 177 -> (3265,3845,4893) -> (369,673,5894) -> (5604,5605) -> (5594,5595) -> (4790+5970) => (7124,3569,4843) |
Class |
|
Type |
Reference
|
Gene |
177 | AGER; advanced glycosylation end-product specific receptor |
3265 | HRAS; HRas proto-oncogene, GTPase |
3845 | KRAS; KRAS proto-oncogene, GTPase |
4893 | NRAS; NRAS proto-oncogene, GTPase |
369 | ARAF; A-Raf proto-oncogene, serine/threonine kinase |
673 | BRAF; B-Raf proto-oncogene, serine/threonine kinase |
5894 | RAF1; Raf-1 proto-oncogene, serine/threonine kinase |
5604 | MAP2K1; mitogen-activated protein kinase kinase 1 |
5605 | MAP2K2; mitogen-activated protein kinase kinase 2 |
5594 | MAPK1; mitogen-activated protein kinase 1 |
5595 | MAPK3; mitogen-activated protein kinase 3 |
4790 | NFKB1; nuclear factor kappa B subunit 1 |
5970 | RELA; RELA proto-oncogene, NF-kB subunit |
7124 | TNF; tumor necrosis factor |
4843 | NOS2; nitric oxide synthase 2 |
|
Metabolite |
C21011 | [Protein]-N(epsilon)-(carboxymethyl)lysine |
C21012 | [Protein]-N(epsilon)-(carboxyethyl)lysine |
|
Reference |
|
Authors |
Rouhiainen A, Kuja-Panula J, Tumova S, Rauvala H |
Title |
RAGE-mediated cell signaling. |
Journal |
|
Reference |
|
Authors |
Zong H, Ward M, Stitt AW |
Title |
AGEs, RAGE, and diabetic retinopathy. |
Journal |
|
Reference |
|
Authors |
Ott C, Jacobs K, Haucke E, Navarrete Santos A, Grune T, Simm A |
Title |
Role of advanced glycation end products in cellular signaling. |
Journal |
|
Reference |
|
Authors |
Xie J, Mendez JD, Mendez-Valenzuela V, Aguilar-Hernandez MM |
Title |
Cellular signalling of the receptor for advanced glycation end products (RAGE). |
Journal |
|
Reference |
|
Authors |
Goldin A, Beckman JA, Schmidt AM, Creager MA |
Title |
Advanced glycation end products: sparking the development of diabetic vascular injury. |
Journal |
|
LinkDB |
|